To summarize, increased levels of CS846 in RA patients following anti-TNF-α therapy may reflect the ability or at least an attempt to repair the damaged cartilage matrix resulting from effective disease control and suppression of inflammation. This evidence concerns the gene TNF and rheumatoid arthritis.